These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32139181)

  • 1. Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease.
    Moegle C; Grillon A; Anheim M; Lipsker D; Velter C
    Rev Neurol (Paris); 2020 May; 176(4):292-293. PubMed ID: 32139181
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersexuality and compulsive over-eating associated with transdermal dopamine agonist therapy.
    Hinnell C; Hulse N; Martin A; Samuel M
    Parkinsonism Relat Disord; 2011 May; 17(4):295-6. PubMed ID: 21300562
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempted suicide under high dose dopaminergic therapy including apomorphine.
    Struhal W; Guger M; Hödl S; Ung SC; Bach M; Ransmayr G
    Wien Klin Wochenschr; 2012 Jul; 124(13-14):461-3. PubMed ID: 22797806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of compulsive sexual behaviour and paraphilia in Parkinson's disease.
    Sachdeva J; Harbishettar V; Barraclough M; McDonald K; Leroi I
    J Parkinsons Dis; 2014; 4(4):665-70. PubMed ID: 25213998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced compulsive behaviors: exceptions to the rule.
    Graham NA; Hammond CJ; Gold MS
    Mayo Clin Proc; 2009 Sep; 84(9):846-7; author reply 847. PubMed ID: 19720785
    [No Abstract]   [Full Text] [Related]  

  • 6. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal rotigotine in restless legs syndrome: impulse control disorders.
    Prescrire Int; 2014 Oct; 23(153):239. PubMed ID: 25964969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.
    Antonini A; Chaudhuri KR; Boroojerdi B; Asgharnejad M; Bauer L; Grieger F; Weintraub D
    Eur J Neurol; 2016 Oct; 23(10):1556-65. PubMed ID: 27425586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome.
    Schreglmann SR; Gantenbein AR; Eisele G; Baumann CR
    Parkinsonism Relat Disord; 2012 Feb; 18(2):207-9. PubMed ID: 22030321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
    Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P
    Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic contact dermatitis caused by rotigotine in a transdermal therapeutic system.
    Raison-Peyron N; Guillot B
    Contact Dermatitis; 2016 Aug; 75(2):121-2. PubMed ID: 27385523
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease.
    Courty E; Durif F; Zenut M; Courty P; Lavarenne J
    Clin Neuropharmacol; 1997 Apr; 20(2):140-7. PubMed ID: 9099466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.
    Ceballos-Baumann A; Häck HJ
    Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal rotigotine (Neupro) for Parkinson's disease.
    Med Lett Drugs Ther; 2007 Aug; 49(1268):69-70. PubMed ID: 17712291
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.
    Metman LV; Gillespie M; Farmer C; Bibbiani F; Konitsiotis S; Morris M; Shill H; Bara-Jimenez W; Mouradian MM; Chase TN
    Clin Neuropharmacol; 2001; 24(3):163-9. PubMed ID: 11391128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of apomorphine in patients with advanced Parkinson's disease and different degrees of functional disability.
    Salazar G; Martín J; Fragoso M; Font MA
    Neurologia; 2017; 32(6):407-410. PubMed ID: 26699210
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
    Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.